Physician profile
Melissa E Canter
NPI 1679898381
$2,291.49
in general payments reported to CMS, 2019-2025
25 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,178 · 2022: $658 · 2023: $330 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $455.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $334.59 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $285.41 | 2021-2025 | Breztri, Farxiga |
| Lilly USA, LLC | $208.77 | 2021-2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.98 | 2021-2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $128.01 | 2021-2023 | Spravato |
| Abbott Laboratories | $125.67 | 2021-2022 | |
| Pfizer INC. | $120.12 | 2021-2023 | |
| Novo Nordisk INC | $101.24 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $89.88 | 2021 | |
| Amgen INC. | $84.19 | 2021-2023 | Otezla, Repatha |
| Novartis Pharmaceuticals Corporation | $83.65 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $75.49 | 2021-2022 | |
| Astellas Pharma US INC | $67.85 | 2021-2022 | |
| Eisai INC. | $53.27 | 2021 | |
| Glaxosmithkline, LLC. | $53.08 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $47.96 | 2021-2022 | |
| Axsome Therapeutics, INC. | $45.09 | 2025 | Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $42.68 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $39.60 | 2022-2023 | |
| Lundbeck LLC | $39.02 | 2022-2025 | Vyepti |
| Biohaven Pharmaceutical Holding Company LTD. | $35.65 | 2022 | |
| Dexcom, INC. | $34.02 | 2022 | |
| Amarin Pharma, INC. | $23.23 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.20 | 2021 | |
| Paratek Pharmaceuticals, INC. | $18.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Canter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.